Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Carroll

Showing results (101-110 of 589) with videos related to

Pageof 59
Sort By:
The Journal of Urology|August 19, 2008
What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE databaseDaniel A Barocas, Janet E Cowan, Joseph A Smith, et al.
The Journal of Urology|November 12, 2003
Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE)Matthew R Cooperberg, Deborah P Lubeck, Shilpa S Mehta, et al.
Journal of the National Cancer Institute|July 3, 2003
National practice patterns and time trends in androgen ablation for localized prostate cancerMatthew R Cooperberg, Gary D Grossfeld, Deborah P Lubeck, et al.
Urology Practice|March 26, 2019
Variation and Predictors of Surgical Case Costs among UrologistsLindsay A Hampson, Anobel Y Odisho, Maxwell V Meng, et al.
Seminars in Urologic Oncology|August 29, 2002
Neoadjuvant strategies for prostate cancer prior to radical prostatectomyMaxwell V Meng, Gary D Grossfeld, Peter R Carroll, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|December 24, 2009
UroVysion testing can lead to early identification of intravesical therapy failure in patients with high risk non-muscle invasive bladder cancerJared M Whitson, Anna B Berry, Peter R Carroll, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 20, 2007
Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancerStacey L Hart, David M Latini, Janet E Cowan, et al.
BJU International|September 20, 2014
Trans-Pacific variation in outcomes for men treated with primary androgen-deprivation therapy (ADT) for prostate cancerMatthew R Cooperberg, Shiro Hinotsu, Mikio Namiki, et al.
Currents in Pharmacy Teaching & Learning|June 17, 2020
Evaluation of a vaccination training program for pharmacy graduands in AustraliaPeter R Carroll, Yihua Chen, Pechdau Vicheth, et al.
Urology|September 17, 2002
Patterns of failure after primary local therapy for prostate cancer and rationale for secondary therapyGary D Grossfeld, Yu-ping Li, Deborah P P Lubeck, et al.
Pageof 59

Showing results (101-110 of 589) with videos related to

Sort By:
Pageof 59
The Journal of Urology|August 19, 2008
What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE databaseDaniel A Barocas, Janet E Cowan, Joseph A Smith, et al.
The Journal of Urology|November 12, 2003
Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE)Matthew R Cooperberg, Deborah P Lubeck, Shilpa S Mehta, et al.
Journal of the National Cancer Institute|July 3, 2003
National practice patterns and time trends in androgen ablation for localized prostate cancerMatthew R Cooperberg, Gary D Grossfeld, Deborah P Lubeck, et al.
Urology Practice|March 26, 2019
Variation and Predictors of Surgical Case Costs among UrologistsLindsay A Hampson, Anobel Y Odisho, Maxwell V Meng, et al.
Seminars in Urologic Oncology|August 29, 2002
Neoadjuvant strategies for prostate cancer prior to radical prostatectomyMaxwell V Meng, Gary D Grossfeld, Peter R Carroll, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|December 24, 2009
UroVysion testing can lead to early identification of intravesical therapy failure in patients with high risk non-muscle invasive bladder cancerJared M Whitson, Anna B Berry, Peter R Carroll, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 20, 2007
Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancerStacey L Hart, David M Latini, Janet E Cowan, et al.
BJU International|September 20, 2014
Trans-Pacific variation in outcomes for men treated with primary androgen-deprivation therapy (ADT) for prostate cancerMatthew R Cooperberg, Shiro Hinotsu, Mikio Namiki, et al.
Currents in Pharmacy Teaching & Learning|June 17, 2020
Evaluation of a vaccination training program for pharmacy graduands in AustraliaPeter R Carroll, Yihua Chen, Pechdau Vicheth, et al.
Urology|September 17, 2002
Patterns of failure after primary local therapy for prostate cancer and rationale for secondary therapyGary D Grossfeld, Yu-ping Li, Deborah P P Lubeck, et al.
Pageof 59